We are monitoring the impact of COVID-19 on Europe Cancer Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1345
Share on
Share on

Europe Cancer Vaccines Market By Treatment Type (Prophylactic And Therapeutic), By Cancer Type - (Prostate, Cervical, Colorectal, Throat, And Others), By Vaccine Type - ( Tumour Cell, Dendritic Cell, Genetic And Protein/Peptide Vaccines), By End User - (Cancer Treatment Centres, Research Institutes) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Pulished: February, 2020
ID: 1345
Pages: 145

The size of the European Cancer Vaccines Market was worth USD 1.01 billion in 2020 and estimated to reach $ 1.85 billion by the end of 2025, with a growing potential of 16.29%.  

Therapeutic vaccines are intended to treat existing cancer by boosting the body’s natural immune response against cancer cells. Mostly, therapeutic vaccines are a form of immunotherapy. The numerous immune effector mechanisms mobilized by therapeutic vaccination precisely attack and destroy cancer cells and leave normal cells. Thus, therapeutic cancer vaccines, in general, may be used to inhibit further growth of advanced cancers, relapsed tumors that are refractory to conventional therapies, such as radiation therapy, surgery, and chemotherapy.

Europe cancer vaccines market is primarily driven by the rising number of people with cancer, increasing public awareness of vaccines, smoking and excessive alcohol intake, strong late-stage pipeline Vaccines, vendors' patient-assistance programs, and major factors driving the growth of the market. Stringent regulations for the approval, Vaccine costs are the factors limiting the growth of the market.

Based on Cancer type, the market is segmented into Prostate, Cervical, Colorectal, Throat, and others. Based on the Vaccine type, the market is segmented into Protein and Peptide-based, Tumour cell, Dendritic cell, Genetic vaccines, and Others. Based on End Users, the market is segmented into Cancer Treatment Centres and Research Institutes. Based on Geography, the European Cancer Vaccines Therapeutics market is analyzed under various regions, namely U.K, Germany, France, Italy, and Spain.

Key players in the European cancer vaccines market are Dendreon, GlaxoSmithKline, and Merck. Companies with their products in the pipeline are Aduro Biotech, Advantagene, Advaxis, Agenus, Altor BioScience, Argos Therapeutics, AVAX Technologies, Bavarian  Nordic, Biothera, Celldex Therapeutics, CureVac, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Inovio Pharmaceuticals, ISA Pharmaceuticals, Juvaris Biotherapeutics, NewLink Genetics, Northwest Biotherapeutics, NovaRx,  OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Sotio, Transgene, Ubivac, Vaccinogen, and Vaxon Biotech.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology Data                   

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Treatment type                        

                                5.1.1 Prophylactic           

                                5.1.2 Therapeutic            

                                5.1.3 Y-o-Y Growth Analysis, By Cancer Type       

                                5.1.4 Market Attractiveness Analysis, By Cancer type      

                                5.1.5 Market Share Analysis, By Cancer Type       

                5.2 Cancer Type               

                                5.2.1 Introduction           

                                5.2.2 Prostate Cancer    

                                5.2.3 Cervical Cancer     

                                5.2.4 Colorectal Cancer 

                                5.2.5 Throat Cancer        

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Cancer Type       

                                5.2.8 Market Attractiveness Analysis, By Cancer type      

                                5.2.9 Market Share Analysis, By Cancer Type       

                5.3 Vaccine Type                             

                                5.3.1 Introduction           

                                5.3.2 Tumour cell Vaccines          

                                5.3.3 Protein or Peptide Vaccines            

                                5.3.4 Genetic Vaccines  

                                                5.3.4.1 DNA Vaccines

                                                5.3.4.2 RNA Vaccines

                                5.3.5 Dendritic cell Vaccines       

                                5.3.6 other Vaccines      

                                5.3.7 Y-o-Y Growth Analysis, By Vaccine Type     

                                5.3.8 Market Attractiveness Analysis, By Vaccine Type    

                                5.3.9 Market Share Analysis, By Vaccine Type     

                5.4 End Users                   

                                5.4.1 Introduction           

                                5.4.2 Cancer Treatment Centers

                                5.4.3 Research Institutes             

                                5.4.4 Y-o-Y Growth Analysis, By End User              

                                5.4.5 Market Attractiveness Analysis, By End User            

                                5.4.6 Market Share Analysis, By End User             

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment Type

                                                6.1.3.3 By Cancer Type

                                                6.1.3.4 By Vaccine Type

                                                6.1.3.5 By End User

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment Type

                                                6.1.4.3 By Cancer Type

                                                6.1.4.4 By Vaccine Type

                                                6.1.4.5 By End User

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment Type

                                                6.1.5.3 By Cancer Type

                                                6.1.5.4 By Vaccine Type

                                                6.1.5.5 By End User

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Merck & co                 

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Dendreon                   

                8.3 Glaxosmithkline                       

                8.4 AstraZeneca plc                        

                8.5 Aduro BioTech                          

                8.6 MedImmune                             

                8.7 Sanofi                           

                8.8 Galena Biopharma                   

                8.9 Ubivac                          

                8.10 Oxford Biomedica                 

                8.11 Immunofrontier Inc                              

                8.12 Oncovir Inc                               

                8.13 Immune Cell Therapy (ICT)                

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Cancer Vaccines Market, By Treatment Type, From 2020 to 2025 (USD Million)
  2. Europe Prophylactic Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  3. Europe Therapeutic Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe Cancer Vaccines Market, By Cancer Type, From 2020 to 2025 (USD Million)
  5. Europe Prostate Cancer Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe Cervical Cancer Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  7. Europe Colorectal Cancer Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  8. Europe Throat Cancer Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  9. Europe Cancer Vaccines Market, By Vaccine Type, From 2020 to 2025 (USD Million)
  10. Europe Tumour cell Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  11. Europe Protein or Peptide Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  12. Europe Genetic Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  13. Europe Dendritic cell Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  14. Europe Cancer Vaccines Market, By End User , From 2020 to 2025 (USD Million)
  15. Europe Cancer Treatment Centers' Vaccine Usage Market, By Region, From 2020 to 2025 (USD Million)
  16. Europe Research Institutes' Vaccine Usage Market, By Region, From 2020 to 2025 (USD Million)
  17. U.K. Cancer Vaccines Market, By Treatment Type, From 2020 to 2025 (USD Million)
  18. U.K. Cancer Vaccines Market, By Cancer Type, From 2020 to 2025 (USD Million)
  19. U.K. Cancer Vaccines Market, By Vaccine Type, From 2020 to 2025 (USD Million)
  20. U.K. Cancer Vaccines Market, By End User , From 2020 to 2025 (USD Million)
  21. Germany Cancer Vaccines Market, By Treatment Type, From 2020 to 2025 (USD Million)
  22. Germany Cancer Vaccines Market, By Cancer Type, From 2020 to 2025 (USD Million)
  23. Germany Cancer Vaccines Market, By Vaccine Type, From 2020 to 2025 (USD Million)
  24. Germany Cancer Vaccines Market, By End User , From 2020 to 2025 (USD Million)
  25. France Cancer Vaccines Market, By Treatment Type, From 2020 to 2025 (USD Million)
  26. France Cancer Vaccines Market, By Cancer Type, From 2020 to 2025 (USD Million)
  27. France Cancer Vaccines Market, By Vaccine Type, From 2020 to 2025 (USD Million)
  28. France Cancer Vaccines Market, By End User , From 2020 to 2025 (USD Million)
  29. Italy Cancer Vaccines Market, By Treatment Type, From 2020 to 2025 (USD Million)
  30. Italy Cancer Vaccines Market, By Cancer Type, From 2020 to 2025 (USD Million)
  31. Italy Cancer Vaccines Market, By Vaccine Type, From 2020 to 2025 (USD Million)
  32. Italy Cancer Vaccines Market, By End User , From 2020 to 2025 (USD Million)
  33. Spain Cancer Vaccines Market, By Treatment Type, From 2020 to 2025 (USD Million)
  34. Spain Cancer Vaccines Market, By Cancer Type, From 2020 to 2025 (USD Million)
  35. Spain Cancer Vaccines Market, By Vaccine Type, From 2020 to 2025 (USD Million)
  36. Spain Cancer Vaccines Market, By End User , From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample